Program – 24th Conference – Day 2

10th GCC Neurology Meeting

24th Saudi Neurology Society Meeting

08-10 February 2018

———————————————————————–

DAY 2 – Friday (09 February 2018)

———————————————————————–

Session 5: Stroke            

Chairpersons: Drs. Waleed Khoja, Ali Alkhathami, Adel Al-Hazzani       

  • 08:00am – 08:20am          Update on Atrial Fibrilation Management. Dr Saeed Alghamdi (Jeddah – KSA)    
  • 08:20am – 08:40am          Reperfusion in Acute Ischemic Stroke Dr Fahmi Alsenani (Riyadh – KSA)              
  • 08:40am – 09:00am          Carotid Stenosis Management. Dr Abdullah Kutbi (Jeddah – KSA)            
  • 09:00am – 09:20am          “SITS” MENA Registry / Angelus Initiative. Dr. Suhail Alrukn (Dubai – UAE)          
  • 09:20am – 09:40am          Embolic Stroke of Undetermined Origin. Dr Nasser Alotaibi (Riyadh – KSA)         

———————————————————————–

Symposium

  • 09:40am – 10:10am          Symposia (Merck)
  • Optimizing benefit-risk of DMD choice. Dr. Mohammed Al-Jumaah
  • Chairperson: Dr. Abdelgader Al-Daif

———————————————————————–

10:10am – 10:30am

BREAK

———————————————————————–

Session 6: Critical Care Neurology          

Chairpersons: Drs. Ayman Qasas, Abdulrahman Altahan, Hussain Al Qahtani              

  • 10:30am – 10:50am          The Unconscious patient – The Neurologist Perspective. Dr Faisal Alswaidan (Riyadh, KSA)               
  • 10:50am – 11:10am          CNS related infections. Dr Tariq Maghrabi (Jeddah – KSA)           
  • 11:10am – 11:30am          The flaccid patient in the ICU. Dr Omar Ayoub (Jeddah, KSA)      

———————————————————————–

11:30am – 01:00pm
Friday Prayer and Lunch
Followed by SNS Business Meeting

———————————————————————–

Symposium

  • 01:00pm – 01:30pm          Symposia (ALLERGAN)
  • Botulinum Toxin and Chronic Migraine. Andrew Blumenfeld, Germany
  • Chairperson: Dr. Jasem Alhashel

———————————————————————–

Session 7: Neuromuscular          

Chairpersons: Drs. Areej Bushnaq, TalalAlHarbi, Aysha Shareef               

  • 01:30pm – 01:50pm          Duschenne muscular dystrophy in Saudi ArabiaDr Abdulaziz AlSamman (Riyadh, KSA)  
  • 01:50pm – 02:10pm          Neuromuscular Variant of CIDP. Dr Abubaker Al Madani (Dubai, UAE)  
  • 02:10pm – 02:30pm          Updated in Management of MG. Dr Mazen Dimachkie (USA)    
  • 02:30pm – 02:50pm          Spinal Muscular Athropy – Local Experience. Dr Hani AlKhaldi (Alkhobar, KSA)  
  • 02:50pm – 03:10pm          Neuromuscular Registry. Dr. Ali Shehri (Riyadh, KSA)    
  • 03:10pm – 03:30pm          Plasma Exchange in Neurology. Dr Mazen Dimachkie (USA)        

———————————————————————–

Symposium

03:30pm – 04:00pm          Symposia (Biologix)

  • Spinal Muscular Atrophy – Standards of Care and Emerging Treatments. Dr. Eduardo Tixzano, Spain
  • Chairperdon: Dr. Mohammed Al-Jumaah

———————————————————————–

Session 8: FREE COMMUNICATION        

Chairpersons: Drs. Bander Aljefen, Majed AlOtaibi, Yousef Al-Khalaf         

  • 04:00pm – 04:10pm          The effect of vitamin D on multiple sclerosis relapses and functional disability: A systematic review. Fawzi Babtain, Waleed Al Shahrani (King Khalid University, Abha)
  • 04:10pm – 04:20pm          The Relationship Between Neuromyelitis Optica (NMO), Relapsing Remitting Multiple Sclerosis (RRMS) And Systemic Autoimmunity. Ashwaq Alshahrani (KFSH – Riyadh) 
  • 04:20pm – 04:30pm          1-Year follow-up efficacy of Fingolimod in the treatment of Relapsing-Remitting multiple sclerosis (RR-MS) among Saudi Patients. Alaa Hijji, Waleed Khoja (PSMMC – Riyadh) 
  • 04:30pm – 04:40pm         Treatment adherence and satisfaction among Multiple Sclerosis patients, CORSS Sectional Study, Saudi Arabia. Adel Alhazzani, Noof Alamri, Mohammed Saeed Alqahtani, Mohammed Alahmari, LeenSarhan, ShahadAlkhashrami, MuhannadAsiri, Adel Alfaifi (College of Medicine, King Khalid University, Abha, Saudi Arabia)
  • 04:40pm – 04:50pm         Natalizumab treatment for Relapsing-Remitting Multiple Sclerosis: The Experience from Saudi Arabia. Hussein Algahtani1, Bader Shirah2, Hind Abobaker3, Nebras Alghanaim3, Fatemah Kamel4 (King Abdulaziz Medical City/ King Saud bin Abdulaziz University for Health Sciences, Jeddah)  
  • 04:50pm – 05:00pm         Clinical Association and Biological Risk Factors of Cerebral Venous Sinus Thrombosis. Saba Naser Sairafi, A. Alabdulwahab, O. Basheir, A. Abdullah, A. Alamri (Imam Abdulrahman Bin Faisal University)
  •   05:00pm – 05:10pm           Cerebral Venous Thrombosis Case Series at King Fahad Medical City: Exploring Treatment Safety and Efficacy of Direct Oral Anticoagulants. AsaadBafaraj, Abdullah Badahman, SoudaElSheikh, Rana Al Dosary, Mukhtar AlOmar, NaimKajtazi, Mohammed AlHazzaa, Fahmi Al Senani, Mohammed AlSheef (KFMC – Riyadh)

———————————————————————–

Symposium

  •  05:10pm – 05:40pm          Symposia (HEKMA)
  • Perampanel: A new anticonvulsant with noval mechanism of action . Dr. Ahmad Beydoun, Lebanon    
  • Chairperson: Dr. Salah Albaz       

 ———————————————————————–

END OF DAY 2

07:30PM GALA DINNER

———————————————————————–